AEGLEA BIOTHERAPEUTICS INC
(00773J103)
ファンドの報告 AEGLEA BIOTHERAPEUTICS INC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Nantahala Capital Management LLC | 2,852,260 | $19,538k | Jun 30, 2019 | Aug 14, 2019 | |
| Orbimed Advisors LLC | 2,165,524 | $14,834k | Jun 30, 2019 | Aug 14, 2019 | |
| Baker BROS Advisors LP | 1,713,604 | $11,738k | Jun 30, 2019 | Aug 14, 2019 | |
| Rock Springs Capital Management LP | 800,000 | $5,480k | Jun 30, 2019 | Aug 14, 2019 | |
| Renaissance Technologies LLC | 545,000 | $3,733k | Jun 30, 2019 | Aug 12, 2019 | |
| Deerfield Management Company LP Series C | 500,046 | $3,425k | Jun 30, 2019 | Aug 14, 2019 | |
| Deltec Asset Management LLC | 47,864 | $328k | Jun 30, 2019 | Jul 29, 2019 | |
| Jacobs LEVY Equity Management Inc | 47,853 | $328k | Jun 30, 2019 | Aug 13, 2019 | |
| Algert Global LLC | 22,060 | $151k | Jun 30, 2019 | Aug 14, 2019 | |
| Sectoral Asset Management Inc | 12,954 | $89k | Jun 30, 2019 | Aug 14, 2019 | |
| Panagora Asset Management Inc | 2,110 | $14k | Jun 30, 2019 | Aug 9, 2019 |